eudragit-e has been researched along with chitosan in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fischinger, K; Hasanovic, A; Hollick, C; Valenta, C | 1 |
Kumar, P; Pillay, V; Singh, I | 1 |
Campos, JC; Costa, PJ; Ferreira, DC; Lima, S; Reis, S | 1 |
3 other study(ies) available for eudragit-e and chitosan
Article | Year |
---|---|
Improvement in physicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acyclovir; Animals; Calorimetry, Differential Scanning; Cations; Chitosan; Hydrogen Bonding; In Vitro Techniques; Liposomes; Minoxidil; Particle Size; Phase Transition; Polymers; Polymethacrylic Acids; Skin Absorption; Spectroscopy, Fourier Transform Infrared; Swine | 2010 |
Site-specific delivery of polymeric encapsulated microorganisms: a patent evaluation of US20170165201A1.
Topics: Adhesiveness; Alginates; Animals; Chitosan; Drug Delivery Systems; Gastrointestinal Tract; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Patents as Topic; Polymers; Polymethacrylic Acids; Probiotics | 2018 |
Swellable polymeric particles for the local delivery of budesonide in oral mucositis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Budesonide; Cell Line; Chitosan; Drug Delivery Systems; Drug Liberation; Humans; Particle Size; Polymers; Polymethacrylic Acids; Stomatitis | 2019 |